Reddit Posts
$RDHL, Army benefits, FDA grant approval and more...
Feetr Data Dump: RDHL NEGG EYPT BETS LSDI WISA
$RDHL Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia
Feetr Data Dump: ATXI CREV RDHL VVOS WHLR YOSH Post image
RDHL : who was there for it today? Who’s with me tomorrow?
RDHL short squeezing. Warrants your look.
$RDHL alert 🚨 at .4 many cycles ago with target 2.7🎯🎯🤫🤐😶🌫️🙏🏽👇🏽
RDHL - 11M share float, could be the one we been wanting.
💰💰💰Good morning! #premarket #watchlist 01/27 $AUVI -Applied UV, Inc. Retains Legal Counsel to Investigate Potential Illegal Naked Short Selling (+51%), $BZFD -BuzzFeed to Use ChatGPT Creator OpenAI to Help Create Quizzes and Other Content (+34%), $RDHL -old news+big volume (+29%)
RDHL up 35 % ? Let's see how high it goes
RDHL called last week...nice pop today
RDHL reversal signal 2 days ago.. RSI very low and heavy oversold... technically ready for a pop and news is coming about the sale of the asset and extinction of debts
Penny stocks ready to pop on news in next few days.. COMS, VGFC and RDHL
💰💰💰Good morning! #premarket #watchlist 10/19 $KTRA -Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Study, $RDHL -RedHill's Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Patent, $SOBR -Secures Large Industrial Customer
💰💰💰Good morning! #premarket #watchlist 10/19 $KTRA -Pauses REM-001 Program to Conserve Funds to Support VAL-083 International Registrational Study, $RDHL -RedHill's Oral Broad-Acting Antiviral, Opaganib, Granted New COVID-19 Treatment Patent, $SOBR -Secures Large Industrial Customer
💰💰💰Good morning! #premarket #watchlist 09/26 $RDHL -potential strategic transaction with respect to Movantik®, $LVTX -Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, $ISPC -no recent news + good chart
💰💰💰Good morning! #premarket #watchlist 09/26 $RDHL -potential strategic transaction with respect to Movantik®, $LVTX -Seagen and LAVA Therapeutics Announce Exclusive Worldwide License Agreement to Advance LAVA-1223, $ISPC -no recent news + good chart
$RDHL 5 drugs in the pipeline all in phase 2 and 3 …covid drug news just came out …company makes their market cap every 2 q’s …..undervalued in every sense possible IMO ….$VERU is about the company but does even have revenue.
$RDHL top 10 undervalued biopharm in the market IMO.load up on bears markets and dump on bulls market or with news.these are the tickers that can make you rich.my original account is (sammy2607) NFA
$RDHL invest in undervalued companies that can squeeze that way nobody is bagholding.5 drugs in the pipeline all in phase 2 and 3….small float…lots of ftd are due..original account(sammy2607)look at my post history
💰💰💰Good morning! #premarket #watchlist 06/24 $TBLT -extra stock offering, $BHAT -old news, public stock offering. bankruptsy, $RDHL -slashes workforce as biotech downturn deepens , $MITQ -uthorizes $1 Million Share Repurchase Program, $ZEN -Nears Agreement With Group Led by H&F, Permira
💰💰💰Good morning! #premarket #watchlist 06/24 $TBLT -extra stock offering, $BHAT -old news, public stock offering. bankruptsy, $RDHL -slashes workforce as biotech downturn deepens , $MITQ -uthorizes $1 Million Share Repurchase Program, $ZEN -Nears Agreement With Group Led by H&F, Permira
💰💰💰Good morning! #premarket #watchlist 06/24 $TBLT -extra stock offering, $BHAT -old news, public stock offering. bankruptsy, $RDHL -slashes workforce as biotech downturn deepens , $MITQ -uthorizes $1 Million Share Repurchase Program, $ZEN -Nears Agreement With Group Led by H&F, Permira
$RDHL Someone on stockwits bought 19 million shares…small float…5 drugs in the pipeline all in phase 2 and 3….covid news came out yesterday also
💰💰💰Good morning! #premarket #watchlist 06/23 $RDHL -On Track for Positive Cash from Operations in H2/22, $BOXD -potential secondary offering , $SMFL -Ramps Up Manufacturing of Milk Dust Lactation Products During Baby Formula Scarcity , $BHAT -Terminates Shelf Takedown Offering
💰💰💰Good morning! #premarket #watchlist 06/23 $RDHL -On Track for Positive Cash from Operations in H2/22, $BOXD -potential secondary offering , $SMFL -Ramps Up Manufacturing of Milk Dust Lactation Products During Baby Formula Scarcity , $BHAT -Terminates Shelf Takedown Offering
💰💰💰Good morning! #premarket #watchlist 06/23 $RDHL -On Track for Positive Cash from Operations in H2/22, $BOXD -potential secondary offering , $SMFL -Ramps Up Manufacturing of Milk Dust Lactation Products During Baby Formula Scarcity , $BHAT -Terminates Shelf Takedown Offering
💰💰💰Good morning! #premarket #watchlist 06/23 $RDHL -On Track for Positive Cash from Operations in H2/22, $BOXD -potential secondary offering , $SMFL -Ramps Up Manufacturing of Milk Dust Lactation Products During Baby Formula Scarcity , $BHAT -Terminates Shelf Takedown Offering
$RDHL insiders bought at $2.50 in December …just got covid news….5 drugs in their pipeline all in phase 2 and 3…small float..40 million market cap..they make that every other Q
$RDHL insiders bought at $2.50 in December …just got covid news….5 drugs in their pipeline all in phase 2 and 3…small float..40 million market cap..they make that every other Q
$RDHL small float..insiders bought at $2.50 in December…5 drugs in the pipeline all in phase 2 and 3🔥🔥
$RDHL small float…insiders bought in December at $2.50🔥🔥 5 drugs in the pipeline all in phase 2 and 3…..covid news just out…called this play at .63 originally and still early…NFA
$CEAD called it at .95 and went up 180% since called💪🏼💪🏼my original account(sammy2607)got banned for saying buy ater puts when it hit $7….$RDHL Called at .63 …ER coming up with covid news…5 drugs in the pipeline all in phase 2 and 3🔥🔥
$RDHL 5 drugs in the pipeline and all in phase 2 and 3….undervalued AF…look at my post history and you will see I’m always early but NEVER wrong💪🏼
Who’s banking on my calls here?ENJOY THE GAINS BOYS💪🏼💪🏼look at my post history,I never miss❗️ $RDHL was the last one I gave you guys and we are extra early ❗️❗️
$RDHL 5 drugs in the pipeline all in phase 2 and 3….er is around the corner…any news and this will fly to heaven IMO
anybody knows about RDHL stocks?
$RDHL small float…5 drugs in the pipeline and all are in phase 2 and 3….extremely undervalued…..with news or volume should be 100-200% gainer IMO
$RDHL 5 drugs in the pipeline all in phase 2 and 3…small float….with news we flying to heaven🔥
IMVESTING FOR 22 YEARS,so if you noticed every ticker that comes on here has a little run than comes the bag holders you ask why?bec hedgies monitor this sub and maybe after a little run up(which retards call a squeeze)they send everything to the darkpool and make synthetic shares.Ortex and fintel?
$AVCT why isn’t anyone talking about this or $RDHL?
$RDHL mid float ☄️7 drugs in the pipeline all in phase 2 and 3☄️moves up with little volume NFA we give this thing volume and you will see a monster
$RDHL mid size float-6 drugs in the pipeline all in phase 2 and 3 and lately had lots of good news☄️with volume this will go to a different planet NFA
$RDHL mid size float-6 drugs in the pipeline all in phase 2 and 3-with volume we flying boys☄️☄️NFA
$RDHL with 290k volume goes up 3%,do the math💰midsize float,6 drugs in the pipeline all in phase 2 and 3,with volume this will go bananas ☄️☄️NFA
Called $SAVA $CRTX $RDHL yesterday LFG☄️☄️NFA
What do you guys think about RDHL? Is it worth investing some money in it? They had yesterday earnings call but the price almost didn’t move.
$RDHL with 40 volume goes up almost 4%,under valued,5 drugs in the pipeline all in phase 2 and 3,earnings are coming up amd for the past 4 years earnings always been great💰NFA with volume this can go bananas ☄️☄️☄️
$RDHL undervalued,with a little volume this thing will go bananas ☄️☄️good long term hood also NFA
$RDHL what the hell happened? I bought two days ago and now it’s tanking. Analysts say “buy” but there’s such low volume. What’s going on with this? Any info for an uneducated moron will help. Thanks all!
$RDHL 46million float,undervalued why isn’t anyone talking about this
$SAVA called it at $44 today hit $99💰💰NOW LOOK AT $RDHL(not financial advice)
$RDHL 1.great fundamentals 2.or was just released 3.not a pump and dump like other tickers mentioned here 4.with volume this will go bananas NFA
$OCGN for the people who didn’t buy when I called it and this is just the beginning 💰💰AMC RDHL SAVA is NEXT RO FLY(not financial advice)and no I’m nkt selling OCGN till who approval
Redhill Biopharma (RDHL) call options. Oct 15 expiry. $5 strike
$RDHL - RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
RedHill Biopharma (NASDAQ / TASE: RDHL)
RDHL anybody else know anything about this?
Squeeze potential for $RDHL? Huge short interest but moving up on some positive news today. Sitting at around $7.50 a share currently.
$RDHL - Short Squeezin Season - Short Interest updated today, lets squeeze some hedgie 🥜
RDHL 53% shorted possible squeeze similar to wish
$RDHL rock today. I am in with 3500 pc.
$RDHL RedHill Biopharma, the company that chose a falling chart as its corporate logo.
Mentions
RDHL is going, whoever called it yesterday well done
RDHL is my play for today.
RDHL good news small float
Your post with title "Achat RDHL 🤑" has been removed from r/pennystocks because it is too short. Posts must have at least 50 characters to ensure meaningful discussions. *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
people on yahoo saying RDHL is going to $5 tomorrow, Friday 2 Aug 2024, then $25... will have to watch pre-market... up almost 100% on thursday...
I like that idea. I made money this morning but it was tighter than normal. I knew it was gonna be a take the first thing you can get kind of day and did my daily 10k on that RDHL I had been watching a few seconds after market open. Sold it 9:32am at that first stall, was a perfect execution, dropped right after that. Im normally tight but that was really tight. I generally would rather sell far before the peak. Took $700 profit, im not mad. But yeah Im going to be more cautious tomorrow, specially on Friday. You always loose money on Friday lol. Thanks for that rule, I appreciate it.
RDHL has moved out of the consolidation range today. It is currently a good investment target. Its investment range is between 0.55 and 0.57.
This looks like my RDHL stock. I'm down 99% on that as well.
Now do $RDHL so I can make my money back there too lol.
We could all pick a bio company, like RDHL, and do this en masse to get it higher
Damn , $RDHL was at 1.10 yesterday , today closed at .65, think it will bounce to .85 tomorrow , gunna grab a few pre market
RDHL recover back to $1 tomorrow ? , seems like an over reaction for a small offering
Only play I see is $RDHL max pain tomorrow is at $1 , that's we're it's heading
Did we all load the dip on $RDHL .ITS OFF THE LOWS
RDHL has considerable upside considering its down 45% today. What can I say, I just like the stock 
RDHL Redhill is going to be the biggest play of the year. I'll bet my life on it.
Buy 1 share and radar it until one Monday or Friday morning it gets an fda approval...then go all in. Until then RDHL has a miracle drug coming very soon. Opoganib cures everything.
Tomorrow is Christmas and stock market closed, but Tuesday you can buy SONX or WKHS, another would be RDHL all pretty good buys right now imo. Merry Christmas.
Had high hopes for RDHL but got shy and sold too soon. Been watching since but now it's flown, those gains have gone to the moon. Lesson for me here is patience, though that's a virtue I'm still learning to hone.
9 Wallstreet analysts offering 12-month price forecasts for Redhill Biopharma Ltd-sp Adr (RDHL) have a share price target of $40. This median of share price forecast represents a 2757.14% upside from the latest price of $1.4 as on 21.12. I guess if you are just holding short term may not be good for you but this could be an excellent long term hold for my portfolio.
$RDHL news drop rumored to come at noon PST time
Thanks for your thoughts. I have no faith in TCBP as of current. Anyone heard of ot have any thoughts on RDHL Redhill Biopharm?? Currently around $1 a share...several analysts...9 say price target over time could potentially reach $40 per share. Enticing...but I haven't heard anyone talking about it.
I buy 1 share to radar it....then one early Monday or Friday morning get an fda approval and go all in. Bio techs require tons of money and always need to dilute or rs. Until then RDHL has a miracle drug being funded by the US Army. Opoganib cures everything from cancer to radiation poisoning to ebola. Yep
Rumors in Israel(Hebrew) that the alrotims masters in Israel got the research ahead big time, because of the war , they have delays in research for Pfizer, so they advancing RDHL ahead.....
News about a new treatment named Talicia for H. pylori infection, which causes stomach pain, has been released. Why is this treatment significant? There's a growing problem in treating this illness: the standard treatment is becoming increasingly ineffective as the bacteria develop resistance. This is partly due to misuse of the treatment, such as not completing the prescribed course or using it unnecessarily. Specifically, the bacteria have grown resistant to 'clarithromycin'. In response, $RDHL has experimented with substituting 'clarithromycin' with 'rifabutin'. According to recent news, this change has proven successful. The cure rates are as follows: Talicia: 84% Competitors' standard treatment (no bacterial resistance): 80-90% Competitors' standard treatment (with bacterial resistance): 58% Placebo: 2% While treatment with clarithromycin might be more effective in non-resistant cases (90% > 84%), its effectiveness drops significantly to 58% when facing resistant bacteria. How large is the market for this treatment? As of 2023: In the US: $300-500 million In the top 7 major markets: $3.5 billion Current company market cap: $18 million It's also crucial to note that bacterial resistance varies by region. For instance, bacteria in the New York region show no resistance, whereas in South Korea, resistance is present. Consequently, doctors' treatment preferences will vary based on regional bacterial resistance profiles. This suggests that $RDHL could dominate in areas with resistant strains, while the situation in other regions may remain unchanged. In conclusion, in regions with high bacterial resistance, the company could gain a strategic edge and potentially easily outperform competitors. Moreover, its treatment is protected from similar competing products by an FDA patent. Therefore, this company is certainly one to watch closely Sources: https://www.prnewswire.com/news-releases/redhill-biopharma-announces-fda-grant-of-5-year-us-market-exclusivity-for-talicia-with-ip-protection-running-to-2034-301997828.html https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-07993-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548423/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797467/
News about a new treatment named Talicia for H. pylori infection, which causes stomach pain, has been released. Why is this treatment significant? There's a growing problem in treating this illness: the standard treatment is becoming increasingly ineffective as the bacteria develop resistance. This is partly due to misuse of the treatment, such as not completing the prescribed course or using it unnecessarily. Specifically, the bacteria have grown resistant to 'clarithromycin'. In response, $RDHL has experimented with substituting 'clarithromycin' with 'rifabutin'. According to recent news, this change has proven successful. The cure rates are as follows: Talicia: 84% Competitors' standard treatment (no bacterial resistance): 80-90% Competitors' standard treatment (with bacterial resistance): 58% Placebo: 2% While treatment with clarithromycin might be more effective in non-resistant cases (90% > 84%), its effectiveness drops significantly to 58% when facing resistant bacteria. How large is the market for this treatment? As of 2023: In the US: $300-500 million In the top 7 major markets: $3.5 billion Current company market cap: $18 million It's also crucial to note that bacterial resistance varies by region. For instance, bacteria in the New York region show no resistance, whereas in South Korea, resistance is present. Consequently, doctors' treatment preferences will vary based on regional bacterial resistance profiles. This suggests that $RDHL could dominate in areas with resistant strains, while the situation in other regions may remain unchanged. In conclusion, in regions with high bacterial resistance, the company could gain a strategic edge and potentially easily outperform competitors. Moreover, its treatment is protected from similar competing products by an FDA patent. Therefore, this company is certainly one to watch closely Sources: https://www.prnewswire.com/news-releases/redhill-biopharma-announces-fda-grant-of-5-year-us-market-exclusivity-for-talicia-with-ip-protection-running-to-2034-301997828.html https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-07993-8 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548423/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797467/
News about a new treatment named Talicia for H. pylori infection, which causes stomach pain, has been released. Why is this treatment significant? There's a growing problem in treating this illness: the standard treatment is becoming increasingly ineffective as the bacteria develop resistance. This is partly due to misuse of the treatment, such as not completing the prescribed course or using it unnecessarily. Specifically, the bacteria have grown resistant to 'clarithromycin'. In response, $RDHL has experimented with substituting 'clarithromycin' with 'rifabutin'. According to recent news, this change has proven successful. The cure rates are as follows: Talicia: 84% Competitors' standard treatment (no bacterial resistance): 80-90% Competitors' standard treatment (with bacterial resistance): 58% Placebo: 2% While treatment with clarithromycin might be more effective in non-resistant cases (90% > 84%), its effectiveness drops significantly to 58% when facing resistant bacteria. How large is the market for this treatment? As of 2023: In the US: $300-500 million In the top 7 major markets: $3.5 billion Current company market cap: $18 million It's also crucial to note that bacterial resistance varies by region. For instance, bacteria in the New York region show no resistance, whereas in South Korea, resistance is present. Consequently, doctors' treatment preferences will vary based on regional bacterial resistance profiles. This suggests that $RDHL could dominate in areas with resistant strains, while the situation in other regions may remain unchanged. In conclusion, in regions with high bacterial resistance, the company could gain a strategic edge and potentially easily outperform competitors. Moreover, its treatment is protected from similar competing products by an FDA patent. Therefore, this company is certainly one to watch closely
Seriously. I killed it on VVOS and RDHL the last few days. Don't be stupid and buy the wrong side of the pump just to end up as someone's exit liquidity. Trading isn't a team sport, anyone who says it is is a liar who just wants your money.
Hold RDHL? im losing -$22 rn but should i hold and wait?
Hold RDHL? im losing -$22 rn but should i hold and wait?
There's other things going on. Therapeutics and biomedical is were it's at. VVOS, CYTO, RDHL. Hopefully HSCS will make a run.
I got in at 1.15 and had a ball with it I’m in $WINT and $WHLR Lots of folks saying $WHLR will expload on Thursday and Friday and $WINT is the long term but it’s got allot of promise and low float so it could jump like crazy upon good news I too feel for the TCBP crAze and lost a good bit but made it all up on RDHL
Finally a Penny stock recovered my losses 😁 800% from RDHL since Monday
$RDHL is prime target for Buyout with recent FDA approval Stock already up 500% in last 2 days
I hit the run up holding this at .09 to .30 I missed this one🤦🏼♂️ Jacking with RDHL
So first RDHL, and now VVOS today. I'm going to predict CALC will soon be next...
Anyone messing with $RDHL today?
RDHL out at $3........?????
I’m going all in on RDHL at market open
CDIO, RDHL. Great gains to be made for you day traders.
YOLO on NEGG or RDHL tomorrow?
Sold wayyyy too early with RDHL…congrats to those who stayed in
>RDHL IMO to late for entry...
RDHL 100+ not a meme
I got down voted in the TCBP thread for my RDHL comments lol
RDHL mooooonnniiinnggg
I can’t give you any advice on this but there is good opportunities, RDHL & $CAPT & ASST yesterday & we’ll see what happens today. Don’t give up! Be self sufficient!
Hey all! It has been a while, really happy to see this place back up! The follow is AI generated and still in active development, use it as a jumping off point and make good decisions: $HSCS TAGS: (long news) Heart Test Laboratories (HSCS) is riding a wave of positive sentiment, with a significant pre-market rise of 34% to $0.27 following a licensing agreement with the Icahn School of Medicine at Mount Sinai. The broader market indicators SPY and QQQ also lean bullish, suggesting a supportive backdrop for HSCS. However, the stock's recent candles show some volatility, with a high of $0.3085 and a low of $0.2377. Given this, I recommend a long position for today. An optimal entry point would be around $0.28, with a first price target of $0.30 and a second price target of $0.32. A stop loss should be set at $0.26 to mitigate potential losses. Confidence levels are 90% for the first target and 70% for the second target. The overall confidence in this trading strategy is 80%. $RDHL TAGS: (short news) RedHill Biopharma Ltd. (RDHL) is riding high on the FDA's five-year market exclusivity grant for its drug, Talicia, causing a significant surge in its share price. The broader market sentiment, as indicated by SPY and QQQ, leans bullish, suggesting a supportive backdrop for RDHL. However, the stock's recent sharp rise and high RSI values hint at overbought conditions, which could trigger a pullback due to profit-taking. For today's trading session, I recommend a short position. Enter at around $1.26, which is slightly above the current price of $1.15, taking advantage of any initial upward momentum. Set the first price target at $1.18 and the second at $1.10, reflecting potential downward pressure after the initial surge. Place a stop loss at $1.30 to limit potential losses if the price unexpectedly rallies. Confidence levels are 90% for the entry price, 92% for the first target, 90% for the second target, and 95% for the stop loss. $WHLR TAGS: (short) Wheeler Real Estate Investment Trust (WHLR) is in the spotlight today, with a pre-market surge of 47% to $0.2426, following a 23% decline the previous day. This volatility suggests a highly reactive market environment for WHLR, potentially driven by investor sentiment or speculative trading. The broader market sentiment from SPY and QQQ leans bullish, which could influence WHLR's price action. The stock's current price is $0.3058, with a high trading volume of 9.33M. The recent candles show a strong upward momentum, with the last candle closing at $0.3029. The 10-day SMA and 20-day EMA are below the current price, indicating a bullish trend. However, the RSI values are below 50, suggesting a potential pullback. Given the current market conditions and technical indicators, I recommend a short position for WHLR. The entry price should be around $0.31, with a first price target of $0.29 and a second price target of $0.27. The stop loss should be set at $0.32. I am 90% confident in the first price target and 80% confident in the second price target. $HKD TAGS: (long) HKD, a tech stock with a market cap of $1.05B, is showing signs of volatility, influenced by broader market sentiment reflected in Zscaler's Q1 results. The SPY and QQQ overviews suggest a bullish trend, but overbought conditions hint at potential pullbacks. HKD's recent trading activity shows a surge in buying pressure, pushing the price above its 10, 20, and 50-day SMAs and EMAs. High RSI values and positive MACD histograms reinforce this upward momentum. For today's session, I recommend a short position due to potential profit-taking after the recent rally. Enter the trade at around $5.60, confident at 92%. If the price rises, exit at the first target of $5.75 (confidence: 90%). If momentum continues, the second target is $5.90 (confidence: 91%). Set a stop loss at $5.45 to limit potential losses, confidence level at 95%. $ICCM TAGS: (long news) IceCure Medical Ltd. (ICCM) is on the radar today, with a recent study bolstering the efficacy of its ProSense® System, a promising development for this $33.78M market cap company. The broader market sentiment leans bullish, as indicated by SPY and QQQ trends, which could provide a supportive backdrop for ICCM. The stock's current price is $1.155, with a significant trading volume of 13.13M. Today's early trading shows a strong upward momentum, with the price reaching $1.265 from an opening of $0.78. Given the positive news and market sentiment, I recommend a long position. Entry at around $1.20, with a first price target of $1.30 and a second price target of $1.40, seems feasible. A stop loss at $1.10 would limit potential downside. Confidence levels are high: 95% for the entry price, 90% for the first target, and 85% for the second target.
Also check out RDHL 5 institutions just bought in but MASSIVELY. do your own DD but something is on the rise. Ibkr states price target at 40$ current price 1, 15 '$ as we speak!
Do u see RDHL continuing to grow tomorrow also or?
I wish I wouldeve seen $RDHL or $BDRX
RDHL was the play we all missed 😔
RDHL was the play we all missed 😔
RDHL jumped at right when premarket opened. I’m just posting news that I came across not giving plays.
RDHL is the pharma play this week. How does this thread seem to give all the wrong plays???
RDHL. TCBP is doing a reverse split, if you buy that be ready to hold the bags. Bots pumping it hard rn.
RDHL - 1 year hold Thank me later. This will age good. Watch.
Hey all! God, it's good to see this place again! For new people, Feetr is an algorithm which finds stocks to day trade and for anyone who hasn't been here in a while, we now use AI to provide analysis as well as price predictions. *Though it's incredibly important that I mention that this feature is still in development and is not 100% accurate.* Here's a blog post that goes into the performance, if you care for that: https://smcn.io/blog/august-performance-2023 If you're asking me personally about these stocks, my enthusiasm dried up within the past hour. Went from some serious potential and runners to, well, the opposite of that. Be smart, make good decisions. Here's the AI analysis for today: $TPST Tempest Therapeutics (TPST) has been on a wild ride recently, with its stock price soaring by 2879% following positive results from an early-mid-stage study. However, the stock has since dropped by more than 50%, reflecting concerns about the company's ability to continue development without additional partnerships. The stock's momentum data shows a mixed picture, with recent figures indicating a slight uptick in online discussion. The broader market sentiment, as gauged by SPY and QQQ overviews, is also mixed. SPY indicates a bearish trend, while QQQ suggests increased price volatility. TPST's current volume stands at 2.07M, which is relatively high for a company of its size. Looking at the technical analysis, TPST's 10-day SMA is significantly higher than its 20-day SMA, suggesting a bullish trend. However, the RSI values are around the mid-range, indicating a balance between buying and selling pressures. The MACD histograms are positive, suggesting a potential bullish reversal. Given these factors, I predict that TPST will have a bullish day. I am 90% confident that the entry price will be $4.00. My first price target is $4.20, with a confidence level of 90%. If the momentum continues, my second price target is $4.40, with a confidence level of 85%. $YGMZ MingZhu Logistics Holdings Limited Ordinary Shares (YGMZ) has been showing a strong upward momentum recently, with a significant increase in trading volume. The stock's current price is $0.6211, and the momentum data stands at 2.01, indicating a positive sentiment among traders. The broader market sentiment, as indicated by SPY and QQQ overviews, is mixed with potential signs of a bullish reversal. However, YGMZ seems to be outperforming the market, which could be due to its low market cap of $10.33M, making it more susceptible to large price swings. Looking at the recent candles, there's a clear upward trend with higher highs and higher lows. The 10-day SMA and 20-day SMA are both below the current price, further confirming the bullish trend. The RSI values are also above 50, indicating more buying pressure. Given these factors, I predict an entry price of $0.65 with 95% confidence. The first price target would be $0.75, with a confidence level of 90%. If the bullish momentum continues, the second price target could reach $0.85, with a confidence level of 90%. $RNAZ TransCode Therapeutics (RNAZ) has been experiencing a significant increase in trading volume, with the current volume at 5.96M, which is quite high for a company with a market cap of only 1.55M. The stock's momentum data shows a positive trend, indicating that it's gaining traction in online discussions. The stock's current price is $0.5359, and it has been showing a bullish trend in the recent trading sessions, with the latest candle closing at $0.55, which is higher than the 10-day SMA of $0.46. The broader market sentiment, as indicated by SPY and QQQ overviews, is mixed, with potential signs of a future bullish reversal. However, the absence of recent news about RNAZ makes it difficult to predict how external factors could impact its price today. Given the current data, I predict an entry price of $0.54 with a confidence level of 92%. My first price target is $0.56, with a confidence level of 90%, and my second price target is $0.58, with a confidence level of 91%. These predictions are based on the stock's recent bullish trend and the positive momentum data. However, due to the mixed market sentiment and lack of recent news, these predictions should be approached with caution. $RDHL RedHill Biopharma Ltd. (RDHL) is poised for a potentially profitable day, following the announcement of their oral opaganib's success in an Ebola virus study. This news has already sparked a 31.1% rise in pre-market trading. The stock's current price is $0.4057, with a market cap of 1.87M and a trading volume of 10.23M. The recent momentum data shows a positive trend in online discussions about RDHL. The 15-minute candles reveal a significant increase in the number of transactions and trading volume, indicating strong buying pressure. The stock's 10-day SMA is at $0.38, below the 20-day SMA of $0.53, suggesting a potential bullish reversal. Given these factors, I predict an entry price of $0.42 with a confidence level of 95%. The first price target is $0.45 with a confidence level of 90%, and the second price target is $0.48 with a confidence level of 90%. These predictions are based on the current economic climate and the positive news surrounding RDHL. $SECO Secoo Holding Limited ADR (SECO) has been on a tear recently, with its stock price skyrocketing by 409% to $1.63 on heavy trading volume. This surge could be attributed to a variety of factors such as positive financial results, strategic partnerships, or market speculation. However, investors should tread carefully as sharp increases can often be followed by equally sharp declines. The broader market sentiment, as gauged by SPY and QQQ overviews, is mixed with potential signs of a future bullish reversal. SECO's current volume stands at 1.81M, indicating high investor interest. The stock's 10-day SMA, 20-day SMA, and 50-day SMA are all below the current price, suggesting a strong upward trend. The RSI values are around 60, indicating that the stock is neither overbought nor oversold. Given the current momentum and market conditions, I predict an entry price of $0.90 with a confidence level of 92%. My first price target is $1.00 with a confidence level of 90%, and my second price target is $1.10 with a confidence level of 91%. These predictions are based on the assumption that the current economic climate and market trends will continue. $TANH Tantech Holdings Ltd. (TANH) has been showing a strong upward momentum in the recent trading sessions. The stock's current price is $1.87, with a market cap of $5.30M. The 10-day SMA is at $1.13 and the 20-day SMA is at $1.31, both below the current price, indicating a bullish trend. The RSI values are also high, suggesting that the stock is currently being heavily bought. The most recent candle shows a close price of $1.8499999, which is higher than the open price of $2.1, indicating a bearish reversal. However, the volume of trades is high, suggesting strong investor interest. Given the current momentum and market sentiment, I predict an entry price of $1.90 with a confidence level of 95%. My first price target is $2.10 with a confidence level of 90%, and my second price target is $2.30 with a confidence level of 85%. In summary, Tantech Holdings Ltd. (TANH) is showing strong bullish momentum, and I expect this to continue in the upcoming trading session. I recommend entering at $1.90 and targeting exits at $2.10 and $2.30.
Way better than what I did. Bought half a small car worth of RDHL at 8ish before splits and kept holding. Their portfolio looked promising during Covid, until it didn’t get the hoped for stage 3 results. At this point it’s just a write-off for me.
RDHL pre pandemic. Decided to hold through multiple reverse splits and sell offs. Currently at -98%
Your post with title "$RDHL HQ in Israel During times of war, widespread diseases and infections can affect a significant number of individuals, leading to a substantial requirement for amoxicillin to treat the injured and ill #WarHealthCrises #AmoxicillinDemand #DiseaseOutbreaks #MedicalShortages" has been automatically removed from r/PennyStocks for being low-effort/spam. (Low word count) probably by u/automod *I am a bot, and this action was performed automatically. Please [contact the moderators of this subreddit](/message/compose/?to=/r/pennystocks) if you have any questions or concerns.*
RDHL... If you know, you know. Under 3.30 is a solid buy.
Do you remember Bored Billionaire? He tweeted RDHL around 1.5 hr ago and it is on the move. Bored come back here we miss you, hundreds of degenerates are waiting.
RDHL - pennystock, peoples thoughts?
Hey /u/Any-Lie-1107 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: FFIE AEI DRRX RSLS RDHL SECO. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
You should have a look at $RDHL. Their research might interest you
Hey /u/Interesting_Guava_23 - I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: RDHL. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
RDHL volume increasing
RDHL right now +34% in germany https://www.asktraders.com/analysis/redhill-biopharma-rdhl-stock-rallied-54-on-us-patent-notice/
What's going on with RDHL, seems to be bouncing from its ATL
RDHL is low key going to pump through the next month.
Gonna ride RDHL and see how high she goes. 25% today was nice.